Cathryn M Clary

Title: Cathryn M Clary: Innovator in Mental Health Treatments

Introduction

Cathryn M Clary is a notable inventor based in New York, NY (US). She has made significant contributions to the field of mental health through her innovative inventions. With a total of two patents to her name, her work focuses on treatments for social anxiety disorder and obsessive-compulsive disorder.

Latest Patents

One of her latest patents is titled "Use of pagoclone for the treatment of social anxiety disorder." This invention provides methods for treating social anxiety disorder by administering specific compounds, including 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone. The patent also mentions the option of administering another compound that acts as a GABA agonist. Another significant patent is related to "Methods of treating obsessive-compulsive disorder," which involves administering a specific compound to address the symptoms of this condition.

Career Highlights

Cathryn M Clary is currently associated with Indevus Pharmaceuticals, Inc., where she continues to work on innovative solutions for mental health issues. Her research and inventions have the potential to improve the quality of life for many individuals suffering from anxiety and obsessive-compulsive disorders.

Collaborations

Throughout her career, Cathryn has collaborated with notable colleagues, including Jeroen Van Beek and Perry S Eisman. These collaborations have likely contributed to the advancement of her research and the successful development of her patents.

Conclusion

Cathryn M Clary is a pioneering inventor whose work in mental health treatments showcases her dedication to improving lives through innovation. Her patents reflect her commitment to addressing significant psychological challenges, making her a valuable contributor to the field.